2,5-二甲基苯甲酰基乙腈 | 53882-93-2

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 2,5-二甲基苯甲酰基乙腈
• 中文别名: 2,5-二甲基苯甲酰乙腈
• 英文名称: 2-cyano-2',5'-dimethylacetophenone
• 英文别名: 2,5-Dimethylbenzoylacetonitrile；3-(2,5-dimethylphenyl)-3-oxopropanenitrile
• CAS: 53882-93-2
• 化学式: C₁₁H₁₁NO
• 分子量: 173.214
• InChiKey: WBEDLANIZRGOMS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.27
• 拓扑面积：
  40.9
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 海关编码：
  2926909090

反应信息

• 作为反应物：
  描述：

  2,5-二甲基苯甲酰基乙腈 在 sodium hydride 、 三苯基膦 、 偶氮二甲酸二乙酯 作用下， 以 四氢呋喃 为溶剂， 生成 Methyl 3-amino-5-(2,5-dimethylphenyl)furan-2-carboxylate
  参考文献：
  名称：

  3-Substituted-(5-arylfuran-2-ylcarbonyl)guanidines as NHE-1 inhibitors

  摘要：

  The C-3 substituents effect on NHE-1 inhibitory activity of (5-arylfuran-2-ylcarbonyl)guanidines, previously identified as potent NHE-1 inhibitors, was investigated. The introduction of amine or alkyl groups at the 3-position of the furan ring, next to the acylguanidine moiety, remarkably improves NHE-1 inhibitory potency. Especially the important finding is that 5-(2,5-dichloro)phenyl and 5-(2-methoxy-5-chloro)phenyl derivatives exhibit high NHE-1 inhibitory activities (IC50 < 0.02 microM) that match those of 3-unsubstituted derivatives.

  DOI：

  10.1016/j.bmcl.2006.12.012
• 作为产物：
  描述：

  2,5-二甲基苯乙酮 在 溴 作用下， 以 乙醚 、 乙醇 、 水 为溶剂， 生成 2,5-二甲基苯甲酰基乙腈
  参考文献：
  名称：

  3-Substituted-(5-arylfuran-2-ylcarbonyl)guanidines as NHE-1 inhibitors

  摘要：

  The C-3 substituents effect on NHE-1 inhibitory activity of (5-arylfuran-2-ylcarbonyl)guanidines, previously identified as potent NHE-1 inhibitors, was investigated. The introduction of amine or alkyl groups at the 3-position of the furan ring, next to the acylguanidine moiety, remarkably improves NHE-1 inhibitory potency. Especially the important finding is that 5-(2,5-dichloro)phenyl and 5-(2-methoxy-5-chloro)phenyl derivatives exhibit high NHE-1 inhibitory activities (IC50 < 0.02 microM) that match those of 3-unsubstituted derivatives.

  DOI：

  10.1016/j.bmcl.2006.12.012

文献信息

• PYRAZOLES AND PYRAZOLOPYRIMIDINES HAVING CRF ANTAGONISTIC ACTIVITY
  申请人：——

  公开号：US20020016333A1

  公开（公告）日：2002-02-07

  The pyrazoles and pyrazolopyrimidines of the formula 1 wherein R 1 , R 2 , R 3 , R 4 and A are as defined herein, have corticotropin releasing factor (CRF) antagonist activity. As such, they are effective in the treatment of a wide range of diseases including stress-related illnesses.

  式1中的吡唑和吡唑嘧啶，其中R1、R2、R3、R4和A的定义如本文所述，具有促肾上腺皮质释放因子（CRF）拮抗活性。因此，它们在治疗包括与压力相关的疾病在内的广泛疾病中是有效的。
• Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity
  申请人：Pfizer Inc.

  公开号：US05712303A1

  公开（公告）日：1998-01-27

  The pyrazoles and pyzazolopyrimidines of the formula ##STR1## wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4 and A are as defined herein, have corticotropin releasing factor (CRF) antagonist activity. As such, they are effective in the treatment of a wide range of diseases including stress-related illnesses.

  公式为##STR1##中的吡唑和吡唑吡嘧啶，其中R.sub.1、R.sub.2、R.sub.3、R.sub.4和A的定义如本文所述，具有促肾上腺皮质激素释放因子（CRF）拮抗剂活性。因此，它们在治疗包括与压力相关的疾病在内的广泛疾病方面是有效的。
• CH557384
  申请人：——

  公开号：——

  公开（公告）日：——
• PYRAZOLES AND PYRAZOLOPYRIMIDINES HAVING CRF ANTAGONIST ACTIVITY
  申请人：PFIZER INC.

  公开号：EP0674624A1

  公开（公告）日：1995-10-04
• PYRAZOLES HAVING CRF ANTAGONIST ACTIVITY
  申请人：PFIZER INC.

  公开号：EP0674624B1

  公开（公告）日：1999-01-20